Galmed Pharmaceuticals Ltd (GLMD)

Currency in USD
2.330
+0.140(+6.39%)
Closed·
Pre Market
2.270-0.060(-2.58%)
·
GLMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 13 days
Fair Value
Day's Range
2.1202.340
52 wk Range
1.15023.800
Key Statistics
Prev. Close
2.33
Open
2.12
Day's Range
2.12-2.34
52 wk Range
1.15-23.8
Volume
293.41K
Average Vol. (3m)
1.79M
1-Year Change
-39.13%
Book Value / Share
11.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Galmed Pharmaceuticals Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Galmed Pharmaceuticals Ltd Company Profile

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule for the treatment of non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study for HIV-associated lipodystrophy and non-alcoholic fatty liver disease. In addition, it develops products for cardiometabolic indications. The company has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with Virginia Commonwealth University to investigate the effect of adding Aramchol to prevent drug resistance to standard-of-care oncology agents in the treatment of hepatoma, cholangiocarcinoma, and colorectal cancer. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Compare GLMD to Peers and Sector

Metrics to compare
GLMD
Peers
Sector
Relationship
P/E Ratio
−0.7x−3.0x−0.5x
PEG Ratio
−0.01−0.030.00
Price / Book
0.3x2.3x2.6x
Price / LTM Sales
-8.8x3.2x
Upside (Analyst Target)
-605.8%43.8%
Fair Value Upside
Unlock8.5%5.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.62 / --
Revenue / Forecast
1.54M / --
EPS Revisions
Last 90 days

GLMD Income Statement

People Also Watch

15.860
HYPD
-0.69%
0.868
IFRX
+2.12%
1.680
CABA
-0.59%
3.260
ETWO
-0.31%
3.020
CYCN
-0.98%

FAQ

What Is the Galmed Pharma (GLMD) Stock Price Today?

The Galmed Pharma stock price today is 2.33

What Stock Exchange Does Galmed Pharma Trade On?

Galmed Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Galmed Pharma?

The stock symbol for Galmed Pharma is "GLMD."

What Is the Galmed Pharma Market Cap?

As of today, Galmed Pharma market cap is 5.26M.

What Is Galmed Pharma's Earnings Per Share (TTM)?

The Galmed Pharma EPS (TTM) is -6.00.

When Is the Next Galmed Pharma Earnings Date?

Galmed Pharma will release its next earnings report on Jul 31, 2025.

From a Technical Analysis Perspective, Is GLMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Galmed Pharma Stock Split?

Galmed Pharma has split 2 times.

How Many Employees Does Galmed Pharma Have?

Galmed Pharma has 5 employees.

What is the current trading status of Galmed Pharma (GLMD)?

As of Jul 18, 2025, Galmed Pharma (GLMD) is trading at a price of 2.33, with a previous close of 2.33. The stock has fluctuated within a day range of 2.12 to 2.34, while its 52-week range spans from 1.15 to 23.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.